Current Report Filing (8-k)
March 27 2015 - 5:31PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): March 27, 2015
DAVITA HEALTHCARE PARTNERS INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
| Delaware |
|
1-14106 |
|
No. 51-0354549 |
| (State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
1551 Wewatta Street
Denver, CO 80202
(Address
of principal executive offices including Zip Code)
(303) 405-2100
(Registrant’s telephone number, including area code)
Not applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| |
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.02. |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
| (b) |
On March 27, 2015, DaVita HealthCare Partners Inc. (the “Company”), announced that Garry E. Menzel, will step down from his position as Chief Financial Officer of the Company as of March 30, 2015.
Mr. Menzel will stay with the Company in a transitional role until a date to be mutually determined in the near future. |
| (c) |
On March 30, 2015, James K. Hilger, age 53, will assume the position of Interim Chief Financial Officer of the Company as successor to Mr. Menzel, in addition to continuing in his current role as Chief
Accounting Officer of the Company. Mr. Hilger became our Chief Accounting Officer in April 2010, after having served as our Vice President and Controller since May 2006. Prior to that, he served as our Vice President, Finance beginning in September
2005. Mr. Hilger was our acting Chief Financial Officer from November 2007 through February 2008, and served as our Interim Chief financial officer from April 2012 until November 2013. |
Mr. Hilger’s base salary will continue at $350,000, which has been in effect since April, 2014.
| Item 9.01. |
Financial Statements and Exhibits. |
|
|
|
| Exhibit
Number |
|
Description |
|
|
| 99.1 |
|
Press Release of DaVita HealthCare Partners Inc. dated March 27, 2015 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
DAVITA HEALTHCARE PARTNERS INC. |
|
|
|
| Date: March 27, 2015 |
|
|
|
/s/ Kim M. Rivera |
|
|
|
|
Kim M. Rivera |
|
|
|
|
Chief Legal Officer |
EXHIBIT INDEX
|
|
|
| Exhibit
Number |
|
Description |
|
|
| 99.1 |
|
Press Release of DaVita HealthCare Partners Inc. dated March 27, 2015 |
Exhibit 99.1
DaVita Healthcare Partners Announces CFO Transition
DENVER (March 27, 2015) – DaVita HealthCare Partners Inc. (NYSE: DVA), one of the nation’s largest and most innovative health care
communities, today announced that Garry E. Menzel, Ph.D., chief financial officer, is leaving to return to the biopharmaceutical industry.
“I have
enjoyed my time at DaVita. It has been a tremendous learning experience,” said Menzel. “I will miss working with teammates who are having such a profound effect on the delivery of health care around the world.”
“I appreciate Garry’s service and contribution to the DaVita Village,” said Kent Thiry, co-chairman and CEO of DaVita HealthCare Partners.
“I wish him all the best as he returns to his professional roots.”
James K. Hilger, will serve as interim chief financial officer effective
March 30, 2015, in addition to continuing in his current role of chief accounting officer. Menzel will remain on board for a period of time to ensure a smooth transition.
DaVita has long maintained a strong finance leadership team. In addition to Hilger, the team includes LeAnne Zumwalt, group vice president, Jim Gustafson,
Vice President of Investor Relations, Chet Mehta, Group Vice President of Finance, and Guy Seay, a division Chief Financial Officer. Collectively they represent over seven decades of DaVita experience and are some of the longest tenured executives
at DaVita. They will serve as partners with Hilger in guiding and executing the financial strategy of the organization.
About DaVita HealthCare
Partners
DaVita HealthCare Partners Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita
Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of Dec. 31, 2014, DaVita Kidney Care operated or provided administrative
services at 2,179 outpatient dialysis centers located in the United States serving approximately 173,000 patients. The company also operated 91 outpatient dialysis centers located in 10 countries outside the United States. HealthCare Partners
manages and operates medical groups and affiliated physician networks in Arizona, California, Nevada, New Mexico, and Florida in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. As of Dec. 31, 2014,
HealthCare Partners provided integrated care management for approximately 837,000 patients. For more information, please visit DaVitaHealthCarePartners.com.
###
Contact Information
Media:
Skip Thurman
(303) 876-6610
Skip.Thurman@DaVita.com
Investors:
Jim Gustafson
(310) 536-2585
Jim.Gustafson@DaVita.com
DaVita (NYSE:DVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Apr 2023 to Apr 2024
